In the last trading session, 6.86 million shares of the Impact BioMedical Inc (AMEX:IBO) were traded. Most recently the company’s share price was $3.60, and it changed around -$1.36 or -27.42% from the last close, which brings the market valuation of the company to $41.40M. IBO currently trades at a discount to its 52-week high of $6.17, offering almost -71.39% off that amount. The share price’s 52-week low was $0.51, which indicates that the current value has risen by an impressive 85.83% since then. We note from Impact BioMedical Inc’s average daily trading volume that its 10-day average is 18.03 million shares, with the 3-month average coming to 2.91 million.

Impact BioMedical Inc (AMEX:IBO) trade information

Instantly IBO has showed a red trend with a performance of -27.42% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 24.84 on recent trading dayincreased the stock’s daily price by 85.51%. The company’s shares are currently up 148.28% year-to-date, but still up 490.07% over the last five days. On the other hand, Impact BioMedical Inc (AMEX:IBO) is 69.81% up in the 30-day period. We can see from the shorts that 12105.0 shares have been sold at a short interest cover period of 0.41 day(s).

Impact BioMedical Inc (AMEX:IBO)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 55.16% of Impact BioMedical Inc shares, and 1.89% of them are in the hands of institutional investors. The stock currently has a share float of 4.22%.

Fidelity Total Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 2.45 shares worth $8816.0, making up 0.00% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 10.77 shares worth around $38764.0, which represents about 0.00% of the total shares outstanding.